The University of Chicago Header Logo

Benjamin Derman

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Hematology and Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Derman BA, Zonder J, Reece D, Cole C, Berdeja J, Stefka AT, Major A, Kin A, Griffith K, Jasielec J, Jakubowiak AJ. Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma. Blood Adv. 2023 10 10; 7(19):5703-5712. PMID: 36763537; PMCID: PMC10539870.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    2. Derman BA. MRD-guided treatment cessation in multiple myeloma. Lancet Haematol. 2023 Nov; 10(11):e867-e868. PMID: 37776871.
      Citations:    Fields:    Translation:Humans
    3. Rojek AE, Kline JP, Feinberg N, Appelbaum DE, Pu Y, Derman BA, Jakubowiak A, Kosuri S, Liu H, Nawas MT, Smith SM, Bishop MR, Riedell PA. Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL. Clin Lymphoma Myeloma Leuk. 2023 Sep 16. PMID: 37827881.
      Citations:    Fields:    
    4. Kubicki T, Dytfeld D, Wróbel T, Jamroziak K, Robak P, Czyz J, Tyczynska A, Druzd-Sitek A, Giannopoulos K, Szczepaniak T, Lojko-Dankowska A, Matuszak M, Gil L, Pula B, Rybka J, Majcherek M, Usnarska-Zubkiewicz L, Szukalski L, Zaucha JM, Mikulski D, Czabak O, Lahoud OB, Stefka A, Derman BA, Jakubowiak AJ. Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial. Br J Haematol. 2023 Sep 10. PMID: 37691005.
      Citations:    Fields:    
    5. Kubicki T, Derman BA, Dytfeld D, Jakubowiak AJ. Measurable residual disease in peripheral blood in myeloma: dream or reality. Curr Opin Oncol. 2023 11 01; 35(6):574-580. PMID: 37621165.
      Citations:    Fields:    
    6. Derman BA, Parker WF. Fair Allocation of Scarce CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma. JAMA. 2023 Jul 31. PMID: 37523170.
      Citations:    Fields:    
    7. Rubinstein SM, Derman BA. Infection rates are high across the multiple myeloma continuum, not just with bispecific antibodies. Eur J Cancer. 2023 Aug; 189:112926. PMID: 37307686.
      Citations:    Fields:    Translation:HumansCells
    8. Dickens LT, Derman B, Alexander JT. Endocrine Society Hypercalcemia of Malignancy Guidelines. JAMA Oncol. 2023 03 01; 9(3):430-431. PMID: 36637830.
      Citations:    Fields:    Translation:Humans
    9. Derman BA, Chari A, Zonder J, Major A, Stefka AT, Jiang K, Karrison T, Jasielec J, Jakubowiak A. A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma. Eur J Haematol. 2023 May; 110(5):564-570. PMID: 36726221.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    10. Dytfeld D, Jamroziak K, Kubicki T, Robak P, Walter-Croneck A, Czyz J, Tyczynska A, Druzd-Sitek A, Giannopoulos K, Nowicki A, Szczepaniak T, Lojko-Dankowska A, Matuszak M, Gil L, Pula B, Rybka J, Majcherek M, Usnarska-Zubkiewicz L, Szukalski L, Konska A, Zaucha JM, Walewski J, Mikulski D, Czabak O, Robak T, Lahoud OB, Zonder JA, Griffith K, Stefka A, Major A, Derman BA, Jakubowiak AJ, Wróbel T. Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023 02; 24(2):139-150. PMID: 36642080; PMCID: PMC10337122.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    11. Wang B, Derman BA, Langerman SS, Johnson J, Zhang W, Jakubowiak A, Chiu BC. Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma. Cancers (Basel). 2022 Oct 29; 14(21). PMID: 36358748; PMCID: PMC9657446.
      Citations: 1     
    12. Derman BA, Kansagra A, Zonder J, Stefka AT, Grinblatt DL, Anderson LD, Gurbuxani S, Narula S, Rayani S, Major A, Kin A, Jiang K, Karrison T, Jasielec J, Jakubowiak AJ. Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study. JAMA Oncol. 2022 09 01; 8(9):1278-1286. PMID: 35862034; PMCID: PMC9305600.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    13. Chiu BC, Zhang Z, Derman BA, Karpus J, Luo L, Zhang S, Langerman SS, Sukhanova M, Bhatti P, Jakubowiak A, He C, Zhang W. Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma. J Hematol Oncol. 2022 08 16; 15(1):106. PMID: 35974364; PMCID: PMC9380317.
      Citations: 2     Fields:    Translation:Humans
    14. Major A, Jakubowiak A, Derman B. Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 11; 22(11):e1000-e1008. PMID: 35922273.
      Citations: 1     Fields:    Translation:Humans
    15. Derman BA, Jakubowiak AJ, Thompson MA. Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma. Blood Cancer J. 2022 07 11; 12(7):108. PMID: 35821020; PMCID: PMC9276661.
      Citations:    Fields:    Translation:Humans
    16. Rouhani SJ, Yu J, Olson D, Zha Y, Pezeshk A, Cabanov A, Pyzer AR, Trujillo J, Derman BA, O'Donnell P, Jakubowiak A, Kindler HL, Bestvina C, Gajewski TF. Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies. J Immunother Cancer. 2022 06; 10(6). PMID: 35732350; PMCID: PMC9226983.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    17. Derman B, Sarosiek S, Beksac M, Castillo JJ. When a Monoclonal Gammopathy Is Not Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-10. PMID: 35394823.
      Citations: 1     Fields:    Translation:Humans
    18. Derman BA, Belli AJ, Battiwalla M, Hamadani M, Kansagra A, Lazarus HM, Wang CK. Reality check: Real-world evidence to support therapeutic development in hematologic malignancies. Blood Rev. 2022 05; 53:100913. PMID: 35272867.
      Citations: 4     Fields:    Translation:Humans
    19. Kanelidis AJ, Miller P, Prabhu N, Dela Cruz MJ, Alenghat FJ, McMullen P, Sarswat N, Derman BA, Polonsky TS, DeCara JM. ATTR Cardiomyopathy Meets Multiple Myeloma: The Importance of Cardiac Biopsy. JACC CardioOncol. 2021 Oct; 3(4):598-601. PMID: 34729534; PMCID: PMC8543135.
      Citations: 1     
    20. Derman BA, Davis AM. Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy. JAMA. 2021 Sep 21; 326(11):1058-1059. PMID: 34546311.
      Citations: 5     Fields:    Translation:Humans
    21. Derman BA, Kosuri S, Jakubowiak A. Knowing the unknowns in high risk multiple myeloma. Blood Rev. 2022 01; 51:100887. PMID: 34479756.
      Citations: 3     Fields:    Translation:Humans
    22. Patel AA, Heng J, Dworkin E, Monick S, Derman BA, DuVall AS, Gurbuxani S, Kosuri S, Liu H, Thirman M, Godley LA, Odenike O, Larson RA, Stock W. Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults. EJHaem. 2021 Aug; 2(3):413-420. PMID: 35844676; PMCID: PMC9175801.
      Citations: 2     
    23. Derman BA, Stefka AT, Jiang K, McIver A, Kubicki T, Jasielec JK, Jakubowiak AJ. Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation. Blood Cancer J. 2021 02 05; 11(2):19. PMID: 33563912; PMCID: PMC7873068.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    24. Jasielec JK, Kubicki T, Raje N, Vij R, Reece D, Berdeja J, Derman BA, Rosenbaum CA, Richardson P, Gurbuxani S, Major S, Wolfe B, Stefka AT, Stephens L, Tinari KM, Hycner T, Rojek AE, Dytfeld D, Griffith KA, Zimmerman TM, Jakubowiak AJ. Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma. Blood. 2020 11 26; 136(22):2513-2523. PMID: 32735641; PMCID: PMC7714092.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    25. Derman BA, Langerman SS, Maric M, Jakubowiak A, Zhang W, Chiu BC. Sex differences in outcomes in multiple myeloma. Br J Haematol. 2021 02; 192(3):e66-e69. PMID: 33216365; PMCID: PMC8182969.
      Citations: 4     Fields:    Translation:Humans
    26. Derman BA, Kordas K, Molloy E, Chow S, Dale W, Jakubowiak AJ, Jasielec J, Kline JP, Kosuri S, Lee SM, Liu H, Riedell PA, Smith SM, Bishop MR, Artz AS. Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients. J Geriatr Oncol. 2021 05; 12(4):585-591. PMID: 33162369.
      Citations: 5     Fields:    Translation:Humans
    27. Carll T, Patel A, Derman B, Hyjek E, Lager A, Wanjari P, Segal J, Odenike O, Fidai S, Arber D. Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement. Blood Adv. 2020 10 13; 4(19):4924-4928. PMID: 33049052; PMCID: PMC7556145.
      Citations: 5     Fields:    Translation:Humans
    28. Derman BA, Schlei Z, Parsad S, Mullane K, Knoebel RW. Changes in Intravenous Immunoglobulin Usage for Hypogammaglobulinemia After Implementation of a Stewardship Program. JCO Oncol Pract. 2021 03; 17(3):e445-e453. PMID: 32822257; PMCID: PMC8257910.
      Citations: 4     Fields:    Translation:Humans
    29. Costa LJ, Derman BA, Bal S, Sidana S, Chhabra S, Silbermann R, Ye JC, Cook G, Cornell RF, Holstein SA, Shi Q, Omel J, Callander NS, Chng WJ, Maiolino A, Stadtmauer E, Giralt S, Pasquini M, Jakubowiak AJ, Morgan GJ, Krishnan A, Jackson GH, Mateos MV, Dimopoulos MA, Facon T, Spencer A, Miguel JS, Hari P, Usmani SZ, McCarthy P, Kumar S, Gay F, Paiva B, Hungria V, Mohty M, Manier S. International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia. 2021 01; 35(1):18-30. PMID: 32778736.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
    30. Derman BA, Jasielec J, Langerman SS, Zhang W, Jakubowiak AJ, Chiu BC. Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis. Blood Cancer J. 2020 08 07; 10(8):80. PMID: 32770051; PMCID: PMC7414120.
      Citations: 13     Fields:    Translation:Humans
    31. Olin RL, Fretham C, Pasquini MC, Arora M, Bhatt VR, Derman B, Giralt SA, Huang LW, Koll T, Lee SM, Lin RJ, Pang L, Popat UR, Weisdorf DJ, Artz A. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes. Blood Adv. 2020 06 23; 4(12):2810-2820. PMID: 32574365; PMCID: PMC7322958.
      Citations: 17     Fields:    Translation:Humans
    32. Derman BA, Jasielec JK, Jakubowiak AJ. Clinician attitudes and practices toward measurable residual disease in multiple myeloma. Br J Haematol. 2020 08; 190(3):470-472. PMID: 32506429.
      Citations: 1     Fields:    Translation:Humans
    33. Derman BA, Zha Y, Zimmerman TM, Malloy R, Jakubowiak A, Bishop MR, Kline J. Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study. J Immunother Cancer. 2020 01; 8(1). PMID: 31940591; PMCID: PMC7057425.
      Citations: 5     Fields:    Translation:HumansCells
    34. Derman BA, Kordas K, Ridgeway J, Chow S, Dale W, Lee SM, Aguada E, Jakubowiak AJ, Jasielec J, Kline J, Kosuri S, Larson RA, Liu H, Mortel M, Odenike O, Pisano J, Riedell P, Stock W, Bishop MR, Artz AS. Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults. Blood Adv. 2019 11 26; 3(22):3488-3498. PMID: 31725894; PMCID: PMC6880895.
      Citations: 20     Fields:    Translation:Humans
    35. Derman BA, Streck M, Wynne J, Christ TN, Curran E, Stock W, Knoebel RW. Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Leuk Lymphoma. 2020 03; 61(3):614-622. PMID: 31680584; PMCID: PMC7028458.
      Citations: 15     Fields:    Translation:HumansCells
    36. Derman BA, Larson RA. Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach? Best Pract Res Clin Haematol. 2019 12; 32(4):101102. PMID: 31779969; PMCID: PMC6903406.
      Citations: 4     Fields:    Translation:Humans
    37. Derman BA, Reiser J, Basu S, Paner A. Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma. Int J Nephrol. 2018; 2018:4654717. PMID: 30254762; PMCID: PMC6145056.
      Citations: 4     
    38. Derman BA, Macklis JN, Azeem MS, Sayidine S, Basu S, Batus M, Esmail F, Borgia JA, Bonomi P, Fidler MJ. Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer. BMC Cancer. 2017 02 16; 17(1):141. PMID: 28209123; PMCID: PMC5312530.
      Citations: 32     Fields:    Translation:HumansCells
    39. Derman BA, Mileham KF, Bonomi PD, Batus M, Fidler MJ. Treatment of advanced squamous cell carcinoma of the lung: a review. Transl Lung Cancer Res. 2015 Oct; 4(5):524-32. PMID: 26629421; PMCID: PMC4630512.
      Citations: 47     
    40. Derman BA, Kwaan HC. Risk Factors, Diagnosis, Management, and Outcome of Splanchnic Vein Thrombosis: A Retrospective Analysis. Semin Thromb Hemost. 2015 Jul; 41(5):503-13. PMID: 26080303.
      Citations: 6     Fields:    Translation:Humans
    41. Duncan FE, Derman B, Woodruff TK. A small field for fertile science: the low visibility of reproductive science in high impact journals. J Assist Reprod Genet. 2014 May; 31(5):511-20. PMID: 24652516; PMCID: PMC4016373.
      Citations: 2     Fields:    Translation:Humans
    Derman's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (132)
    Co-Authors (43)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors